Community-based multi-disease prevention campaigns for controlling human immunodeficiency virus-associated tuberculosis

International Journal of Tuberculosis and Lung Disease

Volumn 16, Issue 4, 2012, Pages 430-436

  Suthar, A B ^a   Klinkenberg, E ^b   Ramsay, A ^a   Garg, N ^c   Bennett, R ^d   Towle, M ^a   Sitienei, J ^e   Smyth, C ^a   Daniels, C ^a   Baggaley, R ^a   Gunneberg, C ^a   Williams, B ^f   Getahun, H ^a   Van Gorkom, J ^b   Granich, Reuben M ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b KNCV TUBERCULOSIS FOUNDATION   (Netherlands)

^c Vestergaard Frandsen Inc   (Switzerland)

^d Vestergaard Frandsen Inc ^*  (United Kingdom)

^e Kenya Ministry of Public Health and Sanitation   (Kenya)

^f STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

Campaign; Community; Control; HIV; Tuberculosis

Indexed keywords

ANTIRETROVIRUS AGENT; BCG VACCINE; COTRIMOXAZOLE; ISONIAZID; PLACEBO;

BCG VACCINATION; CASE FINDING; CHEMOPROPHYLAXIS; COMMUNITY CARE; CONDOM; HEALTH CARE DELIVERY; HEALTH EDUCATION; HEALTH PROMOTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFECTION RISK; MORTALITY; PATIENT COUNSELING; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK REDUCTION; SCREENING TEST; TUBERCULOSIS; TUBERCULOSIS CONTROL;

AFRICA SOUTH OF THE SAHARA; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-HIV AGENTS; ANTITUBERCULAR AGENTS; COMMUNITY HEALTH SERVICES; DELIVERY OF HEALTH CARE; HIV INFECTIONS; HUMANS; ISONIAZID; TUBERCULOSIS; WORLD HEALTH ORGANIZATION;

EID: 84858668831     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.11.0480     Document Type: Review

References (68)

1. World Health Organization. Global tuberculosis control 2011. WHO/HTM/TB/2011.16. Geneva, Switzerland: WHO, 2011. http://www.who.int/entity/ tb/publications/global-report/2011/gtbr11-full.pdf Accessed January 2012.
2. Joint United Nations Programme on HIV/AIDS. Report on the global AIDS epidemic. UNAIDS/10.11E | JC1958E. Geneva, Switzerland: UNAIDS, 2011. http://www.unaids.org/en/media/unaids/contentassets/documents/unaidspublication/ 2011/JC2216-WorldAIDSday-report-2011-en.pdf Accessed January 2012.
3. World Health Organization. WHO policy on collaborative TB/HIV activities. WHO/HTM/TB/2012.1. Geneva, Switzerland: WHO, 2012. http://whqlibdoc.who.int/ publications/2012/9789241503006-eng.pdf Accessed March 2012.
4. World Health Organization. Guidelines for intensified tuberculosis case-finding and isoniazid preventive therapy for people living with HIV in resource-constrained settings. Geneva, Switzerland: WHO, 2011. http://whqlibdoc.who.int/publications/2011/9789241500708-eng.pdf Accessed January 2012.
5. World Health Organization. WHO policy on TB infection control in health-care facilities, congregate settings, and households. WHO/HTM/TB/2009.419. Geneva, Switzerland: WHO, 2009. http://whqlibdoc.who.int/ publications/2009/9789241598323-eng.pdf Accessed January 2012.
6. Lawn S D, Harries A D, Williams B G, et al. Antiretroviral therapy and the control of HIV-associated tuberculosis. Will ART do it? Int J Tuberc Lung Dis 2011; 15: 571-581.
7. World Health Organization. Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach. Geneva, Switzerland: WHO, 2010. http://whqlibdoc.who.int/publications/2010/ 9789241599764-eng. pdf Accessed January 2012.
8. Williams B G, Granich R, De Cock K M, Glaziou P, Sharma A, Dye C. Antiretroviral therapy for tuberculosis control in nine African countries. Proc Natl Acad Sci USA 2010; 107: 19485-19489.
9. Middelkoop K, Bekker L G, Myer L, et al. Antiretroviral therapy and TB notification rates in a high HIV prevalence South African community. J Acquir Immune Defic Syndr 2011; 56: 263-269.
10. Zachariah R, Bemelmans M, Akesson A, et al. Reduced tuberculosis case notification associated with scaling up antiretroviral treatment in rural Malawi. Int J Tuberc Lung Dis 2011; 15: 933-937.
11. Fang C T, Hsu H M, Twu S J, et al. Decreased HIV transmission after a policy of providing free access to highly active antiretroviral therapy in Taiwan. J Infect Dis 2004; 190: 879-885.
12. Granich R M, Gilks C F, Dye C, de Cock K M, Williams B G. Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet 2009; 373: 48-57.
13. Das M, Chu P L, Santos G M, et al. Decreases in community viral load are accompanied by reductions in new HIV infections in San Francisco. PLoS One 2010; 5: e11068.
14. Montaner J S, Lima V D, Barrios R, et al. Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study. Lancet 2010; 376: 532-539.
15. World Health Organization. Global HIV/AIDS response: epidemic update and health sector progress towards universal access. Geneva, Switzerland: WHO, 2011. http://www.who.int/hiv/pub/progress-report2011/hiv-full-report-2011.pdf Accessed February 2012.
16. Nash D, Wu Y, Elula B, Hoosa D, El Sadr W. Program-level and contextual-level determinants of low-median CD4 cell count in cohorts of persons initiating ART in eight sub-Saharan African countries. AIDS 2011; 25: 1523-1533.
17. Braitstein P, Brinkhof M W, Dabis F, et al. Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet 2006; 367: 817-824.
18. Lawn S D, Harries A D, Anglaret X, Myer L, Wood R. Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa. AIDS 2008; 22: 1897-1908.
19. Hirnschall G, Schwartlander B. Treatment 2.0: catalysing the next phase of scale-up. Lancet 2011; 378: 209-211.
20. United Nations. The Millenium Development Goals report. New York, NY, USA: UN, 2011. http://mdgs.un.org/unsd/mdg/Resources/Static/Products/ Progress2011/11-31339%20(E)%20MDG%20Report%202011-Book%20LR.pdf Accessed January 2012.
21. Schwartlander B, Stover J, Hallett T, et al. Towards an improved investment approach for an effective response to HIV/AIDS. Lancet 2011; 377: 2031-2041.
22. Clasen T, Roberts I, Rabie T, Schmidt W, Cairncross S. Interventions to improve water quality for preventing diarrhoea. Cochrane Database Syst Rev 2006; 3: CD004794.
23. World Health Organization. The Global Plan to Stop TB: 2011-2015. Geneva, Switzerland: WHO, 2010. http://www.stoptb.org/assets/documents/global/plan/TB- GlobalPlanToStopTB2011-2015.pdf Accessed January 2012.
24. Fenner F, Henderson D A, Arita I, Jezek Z, Ladnyi I D. Small-pox and its eradication. Geneva, Switzerland: WHO, 1988.
25. de Quadros C A, Andrus J K, Olive J M, Guerra de Macedo C, Henderson D A. Polio eradication from the Western Hemisphere. Annu Rev Public Health 1992; 13: 239-252.
26. de Quadros C A, Olive J M, Hersh B S, et al. Measles elimination in the Americas. Evolving strategies. JAMA 1996; 275: 224-229.
27. Hopkins D R. The Guinea worm eradication effort: lessons for the future. Emerg Infect Dis 1998; 4: 414-415. (Pubitemid 28387422)
28. Natchiar G, Robin A L, Thulasiraj R D, Krishnaswamy S. Attacking the backlog of India's curable blind. The Aravind Eye Hospital model. Arch Ophthalmol 1994; 112: 987-993. (Pubitemid 24228263)
29. Golub J E, Mohan C I, Comstock G W, Chaisson R E. Active case finding of tuberculosis: historical perspective and future prospects. Int J Tuberc Lung Dis 2005; 9: 1183-1203. (Pubitemid 41735596)
30. Raviglione M C, Pio A. Evolution of WHO policies for tuberculosis control, 1948-2001. Lancet 2002; 359: 775-780. (Pubitemid 34215081)
31. Comstock G W. The International Tuberculosis Campaign: a pioneering venture in mass vaccination and research. Clin I nfect Dis 1994; 19: 528-540.
32. Aidi M. Know your CD4 campaign: an approach to increase numbers of people on treatment and enhancing patient empowerment. Windhoek, Namibia: HIV Implementers' Meeting, 2009. [Abstract #1259]
33. AIDSmap. South Africa to launch mass HIV testing drive in April, to test 15 million in one year. London, UK: AIDSmap, 2010. http://www.aidsmap.com/South- Africa-to-launch-mass-HIV-testing-drive-in-April-to-test-15-million-in-one-year/ page/1438260/ Accessed January 2012.
34. Moses P, Kayambo F, Nyangulu M, Ngo'mango'ma L, Kamoto K, Wadud A. Malawi's two annual HIV testing and counseling week campaigns: a review of the results. Kampala, Uganda: The 2008 HIV/AIDS Implementers' Meeting, 2008. [Abstract #1549]
35. World Health Organization. Know your status. HIV campaign receives praise for the achievements accomplished in Lesotho. Geneva, Switzerland: WHO, 2008. http://www.afro.who.int/en/lesotho/press-materials/323-know-your-status-hiv- campaign-receives-praise-for-the-achievements-accomplished-in-lesotho.html Accessed January 2012.
36. Mossdorf E, Stoeckle M, Vincenz A, et al. Impact of a national HIV voluntary counselling and testing (VCT) campaign on VCT in a rural hospital in Tanzania. Trop Med Int Health 2010; 15: 567-573.
37. Human Rights Watch, AIDS Rights Alliance for Southern Africa. A testing challenge: the experience of Lesotho's Universal HIV Counseling and Testing Campaign. New York, NY, USA: Human Rights Watch, 2008. http://www.hrw.org/sites/ default/files/reports/lesotho1108.pdf Accessed January 2012.
38. Corbett E L, Bandason T, Duong T, et al. Comparison of two active case-finding strategies for community-based diagnosis of symptomatic smear-positive tuberculosis and control of infectious tuberculosis in Harare, Zimbabwe (DETECTB): a clusterrandomised trial. Lancet 2010; 376: 1244-1253.
39. Durovni B, Saraceni V, Pacheco A, et al. Impact of tuberculosis (TB) screening and isoniazid preventive therapy (IPT) on incidence of TB and death in the TB/HIV in Rio de Janeiro (THRio) study. Rome, Italy: 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention, 2011. [Abstract #ELBB02]
40. AIDSmap. An intensive household counselling intervention reduces the burden of TB in ZAMSTAR study. London, UK: AIDSmap, 2011. http://www.aidsmap. com/An-intensive-household-counselling-intervention-reduces-the-burden-of-TB-in- ZAMSTAR-study/page/2124011/ Accessed January 2012.
41. Grant A D, Coetzee L, Fielding K L, et al. 'Team up against TB': promoting involvement in Thibela TB, a trial of communitywide tuberculosis preventive therapy. AIDS 2010; 24 (Suppl 5): S37-S44.
42. Sweat M, Morin S, Celentano D, et al. Community-based intervention to increase HIV testing and case detection in people aged 16-32 years in Tanzania, Zimbabwe, and Thailand (NIMH Project Accept, HPTN 043): a randomised study. Lancet Infect Dis 2011; 11: 525-532.
43. Tumwesigye E, Wana G, Kasasa S, Muganzi E, Nuwaha F. High uptake of home-based, district-wide, HIV counseling and testing in Uganda. AIDS Patient Care STDS 2010; 24: 735-741.
44. Grabbe K L, Menzies N, Taegtmeyer M, et al. Increasing access to HIV counseling and testing through mobile services in Kenya: strategies, utilization, and cost-effectiveness. J Acquir Immune Defic Syndr 2010; 54: 317-323.
45. Morin S F, Khumalo-Sakutukwa G, Charlebois E D, et al. Removing barriers to knowing HIV status: same-day mobile HIV testing in Zimbabwe. J Acquir Immune Defic Syndr 2006; 41: 218-224.
46. Wachira J, Kimaiyo S, Ndege S, Mamlin J, Braitstein P. What is the impact of home-based HIV counseling and testing (HBCT) on the clinical status of newly enrolled adults in a large HIV care program in western Kenya? Clin Infect Dis 2012; 54: 275-281.
47. Negin J, Wariero J, Mutuo P, Jan S, Pronyk P. Feasibility, acceptability and cost of home-based HIV testing in rural Kenya. Trop Med Int Health 2009; 14: 849-855.
48. Menzies N, Abang B, Wanyenze R, et al. The costs and effectiveness of four HIV counseling and testing strategies in Uganda. AIDS 2009; 23: 395-401.
49. Lugada E, Millar D, Haskew J, et al. Rapid implementation of an integrated large-scale HIV counseling and testing, malaria, and diarrhea prevention campaign in rural Kenya. PLoS One 2010; 5: e12435.
50. Dye Tde V, Apondi R, Lugada E. A qualitative assessment of participation in a rapid scale-up, diagonally-integrated MDG-related disease prevention campaign in rural Kenya. PLoS One 2011; 6: e14551.
51. Hatcher A M, Turan J M, Leslie H H, et al. Predictors of linkage to care following community-based HIV counseling and testing in rural Kenya. AIDS Behav 2011 Oct 22. [Epub ahead of print]
52. Getahun H, Kittikraisak W, Heilig C M, et al. Development of a standardized screening rule for tuberculosis in people living with HIV in resource-constrained settings: individual participant data meta-analysis of observational studies. PLoS Med 2011; 8: e1000391.
53. Akolo C, Adetifa I, Shepperd S, Volmink J. Treatment of latent tuberculosis infection in HIV infected persons. Cochrane Database Syst Rev 2010; 1: CD000171.
54. Samandari T, Agizew T B, Nyirenda S, et al. 6-month versus 36-month isoniazid preventive treatment for tuberculosis in adults with HIV infection in Botswana: a randomised, doubleblind, placebo-controlled trial. Lancet 2011; 377: 1588-1598.
55. World Health Organization. Save a million lives by 2015: prevent and treat tuberculosis among people living with HIV. Geneva, Switzerland: WHO, 2011. http://www.stoptb.org/assets/documents/resources/publications/acsm/TB-HIV- Brochure-Singles.pdf Accessed January 2012.
56. World Health Organization. Harmonized monitoring and evaluation indicators for procurement and supply management systems. Geneva, Switzerland: WHO, 2011. http://whqlibdoc.who.int/publications/2011/9789241500814-eng.pdf Accessed January 2012.
57. Govindasamy D, van Schaik N, Kranzer K, Wood R M C, Bekker L G. Linkage to HIV care from a mobile testing unit in South Africa by different CD4 count strata. J Acquir Imm Defic Syndr 2011; 58: 344-352.
58. World Health Organization. Guidance on provider-initiated HIV testing and counselling in health facilities. Geneva, Switzerland: WHO, 2007. http://whqlibdoc.who.int/publications/2007/9789241595568-eng.pdf Accessed January 2012.
59. World Health Organization. Same-day diagnosis of tuberculosis by microscopy. Geneva, Switzerland: WHO, 2010. http://www.who.int/tb/dots/ laboratory/whopolicy-same-day-diagnosis-bymicroscopy-july10.pdf Accessed January 2012.
60. World Health Organization. Fluorescent light emitting diode (LED) microscopy for diagnosis of tuberculosis. Geneva, Switzerland: WHO, 2010. http://www.who.int/tb/dots/laboratory/who-policy-led-microscopy-july10.pdf Accessed January 2012.
61. World Health Organization. Automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: Xpert MTB/RIF system policy statement. WHO/HTM/TB/2011.4. Geneva, Switzerland: WHO, 2011. http://whqlibdoc.who.int/publications/2011/ 9789241501545-eng.pdf Accessed January 2012.
62. World Health Organization. Rapid implementation of the Xpert MTB/RIF diagnostic test: technical and operational 'how-to' practical considerations. WHO/HTM/TB/2011.2. Geneva, Switzerland: WHO, 2011. http://whqlibdoc.who.int/ publications/2011/9789241501569-eng.pdf Accessed January 2012.
63. Kosloff B, Haas Pd, Ayles H. Use of containerized laboratories in the ZAMSTAR TB Prevalence Survey in Zambia. 40th Union World Conference on Lung Health, Cancun, Mexico, 2009. Int J Tuberc Lung Dis 2009; 13(Suppl 1): S348. [Abstract #PS-94821]
64. World Health Organization. Revision of the case definition for sputum smear positive pulmonary TB. Geneva, Switzerland: WHO, 2010. http://www.who.int/tb/dots/laboratory/ Proposal%20for%20a%20revision%20of%20the%20case%20definition%20of%20Sputum.pdf Accessed January 2012.
65. Middelkoop K, Kreiswirth B, Myer L, et al. Transmission of TB in a high-prevalence South African community. Rome, Italy: 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention, 2011. [Abstract TUPE 163].
66. Van't Hoog A H, Laserson K F, Githui W A, et al. High prevalence of pulmonary tuberculosis and inadequate case finding in rural western Kenya. Am J Respir Crit Care Med 2011; 183: 1245-1253.
67. Bitega J P, Ngeruka M L, Hategekimana T, Asiimwe A, Binagwaho A. Safety and efficacy of the prepex device for rapid scale-up of male circumcision for HIV prevention in resource-limited settings. J Acquir Immune Defic Syndr 2011; 58: e127-e134.
68. Barone M A, Ndede F, Li P S, et al. The Shang Ring device for adult male circumcision: a proof of concept study in Kenya. J Acquir Immune Defic Syndr 2011; 57: e7-12.